EMA Authorised: Akeega (abiraterone acetate;niraparib (tosilate monohydrate)) — Janssen-Cilag International N.V.

View source ↗

Summary

EMA authorised Akeega, a fixed-dose combination of abiraterone acetate and niraparib (tosilate monohydrate) for castration-resistant prostate cancer, by Janssen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• niraparib (tosilate monohydrate) (niraparib tosilate monohydrate)

Snippet

Status: Authorised. Therapeutic area: Prostatic Neoplasms, Castration-Resistant. MAH: Janssen-Cilag International N.V.. Decision date: 05/03/2026